Precision Oncology Advances in Hematologic Cancers at ASCO25
Dr. John Sweetenham and Dr. Marc Braunstein highlight top research on hematologic malignancies from the 2025 ASCO Annual Meeting, including abstracts on newly diagnosed chronic phase CML, relapsed B-cell lymphoma, and multiple myeloma.
Transcript
Dr. John Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host,
Dr. John Sweetenham. On today's episode, we'll be discussing promising advances in newly diagnosed chronic phase CML, relapsed B-cell lymphoma, multiple myeloma, and other hematologic malignancies that were presented at the 2025 ASCO Annual Meeting. Joining me for…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.